Raymond James & Associates’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.44M | Sell |
44,797
-1,168
| -3% | -$36.6K | ﹤0.01% | 2448 |
|
|
2024
Q2 | $1.38M | Sell |
45,965
-509
| -1% | -$15.4K | ﹤0.01% | 2393 |
|
|
2024
Q1 | $1.48M | Sell |
46,474
-603
| -1% | -$18.5K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $1.4M | Buy |
47,077
+215
| +0.5% | +$5.89K | ﹤0.01% | 2309 |
|
|
2023
Q3 | $1.28M | Sell |
46,862
-28
| -0.1% | -$815 | ﹤0.01% | 2294 |
|
|
2023
Q2 | $1.4M | Sell |
46,890
-970
| -2% | -$28.4K | ﹤0.01% | 2286 |
|
|
2023
Q1 | $1.4M | Sell |
47,860
-340
| -0.7% | -$9.89K | ﹤0.01% | 2249 |
|
|
2022
Q4 | $1.39M | Sell |
48,200
-12,940
| -21% | -$360K | ﹤0.01% | 2231 |
|
|
2022
Q3 | $1.54M | Buy |
61,140
+8,270
| +16% | +$227K | ﹤0.01% | 2132 |
|
|
2022
Q2 | $1.42M | Sell |
52,870
-9,890
| -16% | -$280K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $1.92M | Sell |
62,760
-31,780
| -34% | -$951K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $3.03M | Buy |
94,540
+10,940
| +13% | +$333K | ﹤0.01% | 1876 |
|
|
2021
Q3 | $2.49M | Buy |
83,600
+41,480
| +98% | +$1.28M | ﹤0.01% | 1944 |
|
|
2021
Q2 | $1.23M | Buy |
42,120
+1,420
| +3% | +$40.2K | ﹤0.01% | 2445 |
|
|
2021
Q1 | $1.09M | Sell |
40,700
-26,420
| -39% | -$703K | ﹤0.01% | 2449 |
|
|
2020
Q4 | $1.76M | Sell |
67,120
-119,310
| -64% | -$2.97M | ﹤0.01% | 1970 |
|
|
2020
Q3 | $4.39M | Buy |
186,430
+4,650
| +3% | +$109K | 0.01% | 1297 |
|
|
2020
Q2 | $4.04M | Sell |
181,780
-10,520
| -5% | -$225K | 0.01% | 1322 |
|
|
2020
Q1 | $3.64M | Sell |
192,300
-17,370
| -8% | -$368K | 0.01% | 1215 |
|
|
2019
Q4 | $4.64M | Buy |
209,670
+14,940
| +8% | +$312K | 0.01% | 1303 |
|
|
2019
Q3 | $3.82M | Sell |
194,730
-54,140
| -22% | -$1.08M | 0.01% | 1381 |
|
|
2019
Q2 | $5.04M | Sell |
248,870
-73,530
| -23% | -$1.43M | 0.01% | 1207 |
|
|
2019
Q1 | $6.36M | Sell |
322,400
-39,580
| -11% | -$763K | 0.01% | 1057 |
|
|
2018
Q4 | $6.43M | Sell |
361,980
-5,750
| -2% | -$109K | 0.01% | 978 |
|
|
2018
Q3 | $7.58M | Buy |
367,730
+42,100
| +13% | +$824K | 0.01% | 991 |
|
|
2018
Q2 | $5.95M | Sell |
325,630
-103,730
| -24% | -$1.88M | 0.01% | 1089 |
|
|
2018
Q1 | $7.71M | Buy |
429,360
+11,090
| +3% | +$206K | 0.01% | 914 |
|
|
2017
Q4 | $7.51M | Sell |
418,270
-96,160
| -19% | -$1.7M | 0.01% | 912 |
|
|
2017
Q3 | $9.02M | Buy |
514,430
+11,730
| +2% | +$204K | 0.02% | 792 |
|
|
2017
Q2 | $8.75M | Sell |
502,700
-179,450
| -26% | -$2.98M | 0.02% | 768 |
|
|
2017
Q1 | $10.9M | Buy |
682,150
+101,350
| +17% | +$1.58M | 0.03% | 622 |
|
|
2016
Q4 | $8.47M | Buy |
580,800
+116,300
| +25% | +$1.72M | 0.02% | 709 |
|
|
2016
Q3 | $7.23M | Buy |
464,500
+368,650
| +385% | +$5.79M | 0.02% | 756 |
|
|
2016
Q2 | $1.45M | Sell |
95,850
-20,470
| -18% | -$305K | ﹤0.01% | 1519 |
|
|
2016
Q1 | $1.68M | Sell |
116,320
-16,010
| -12% | -$227K | 0.01% | 1378 |
|
|
2015
Q4 | $2.03M | Buy |
+132,330
| New | +$1.97M | 0.01% | 1253 |
|
|
2015
Q3 | – | Sell |
-101,390
| Closed | -$1.62M | – | 2365 |
|
|
2015
Q2 | $1.62M | Sell |
101,390
-298,320
| -75% | -$4.72M | 0.01% | 1447 |
|
|
2015
Q1 | $6.2M | Buy |
+399,710
| New | +$5.98M | 0.03% | 640 |
|
|
2013
Q4 | – | Sell |
-194,510
| Closed | -$1.95M | – | 2017 |
|
|
2013
Q3 | $1.95M | Buy |
194,510
+2,890
| +2% | +$28.6K | 0.02% | 892 |
|
|
2013
Q2 | $1.8M | Buy |
+191,620
| New | +$1.78M | 0.02% | 861 |
|
Other funds holding RSPH
RRWA
WLPWM
MCM
Raymond James & Associates's RSPH Position: Q3 2024 in Review
Raymond James & Associates reduced its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 2.5% in Q3 2024, selling an estimated $36.6K and leaving 44,797 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2448.
Raymond James & Associates first reported a position in RSPH in Q2 2013 and has held it in 40 quarters since. The position peaked at $10.9M in Q1 2017. 186 funds tracked by Wall St. Rank hold RSPH as of Q3 2024.
- Raymond James & Associates held 44,797 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $1.44M as of Q3 2024.
- Raymond James & Associates sold 1,168 Invesco S&P 500 Equal Weight Health Care ETF shares in Q3 2024, an estimated $36.6K.
- Invesco S&P 500 Equal Weight Health Care ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2448 holding.
- Raymond James & Associates first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q2 2013 and has held it in 40 quarters since.
- Raymond James & Associates's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $10.9M in Q1 2017.
- 186 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.